Griseofulvin enhances the effect of aminolevulinic acid-based photodynamic therapy in vitro

Photomedicine and Laser Surgery

Volumn 24, Issue 2, 2006, Pages 186-191

  Nomura, Jouji ^a   Yanase, Shigeaki ^a   Tokuda, Tohru ^a   Matsumura, Yoshihiko ^a   Sekida, Motoko ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; PATIENT TREATMENT; PHOTODYNAMIC THERAPY; SKIN;

AMINOLEVULINIC ACID; GINGIVA-DERIVED FIBROBLAST LINE; GRISEOFULVIN; HUMAN SQUAMOUS CELL;

AMINO ACIDS;

AMINOLEVULINIC ACID; GRISEOFULVIN; PROTOPORPHYRIN;

ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INFRARED RADIATION; OSTEOSARCOMA; PHASE CONTRAST MICROSCOPY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANTIFUNGAL AGENTS; GRISEOFULVIN; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TUMOR CELLS, CULTURED;

EID: 33744790280     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2006.24.186     Document Type: Article

References (26)

1. Morgan, J., and Oseroff, A.R. (2001). Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. Rev. 49, 71-86.
2. Pass, H.I. (1993). Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-456.
3. Dougherty, T.J. (2002). An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7.
4. Schwetzer, V.G. (1990). Photodynamic therapy for treatment of head and neck cancer. Otolaryngol. Head Neck Surg. 102, 225-232.
5. Nomura, J., Yanase, S., Matsumura, Y., et al. (2004). Efficacy of combined photodynamic and hyperthermic therapy with new light source in an in vivo osteosarcoma tumor model. J. Clin. Laser Med. Surg. 22, 3-8.
6. Kelleher, D.K., Bastian, J., Thews, O., et al. (2003). Enhanced effect of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumors. Br. J. Cancer 89, 405-411.
7. Schaffer, M., Schaffer, P.M., Jori, G., et al. (2002). Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Tumori 88, 407-410.
8. Pogue, B.W., O'Hara, J.A., Demidenko, E., et al. (2003). Photodynamic therapy with verteporfin in radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res. 63, 1025-1033.
9. Peng, Q., Warloe, T., Berg, K., et al. (1997). 5-Aminolevulinic acid-based photodynamic therapy. Cancer 79, 2282-2308.
10. Kennedy, J.C., Pettier, R.H., and Pross, D.C. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol. 6, 143-148.
11. De Matteis, E, and Gibbs, A. (1975). Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-dithoxycarbonyl-1,4-dihydrocollidine and related drugs. Evidence for two basically different mechanisms. Biochem. J. 146, 285-287.
12. Navone, N.M., Buzaleh, A.M., Polo, C.F., et al. (1991). The effect of griseofulvin on the heme pathway-II. An exhaustive analysis during short- and long-term challenge. Gen. Pharm. 22, 1179-1183.
13. Brady, A.M., and Lock, E.A. (1992). Inhibition pf ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals. Arch. Toxicol. 66, 175-181.
14. Denk, H., Kalt, R., Abdelfattah-Gad, M., et al. (1981). Effect of griseofilvin on 5-aminolevulinate synthase and on ferrochelatase in mouse liver neoplastic nodules. Cancer Res. 41, 1535-1538.
15. Tangeras, A. (1986). Effect of decreased ferrochelatase activity on iron and porphyrin content on mitochondria of mice with porphyria induced by griseofulvin. Biochem. Biophys. Acta 882, 77-84.
16. Seidl, J., Rauch, J., Krieg, R.C., et al. (2001). Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer. Int. J. Cancer 92, 671-677.
17. Uehara, M., Inokuchi, T., and Sano, K. (1996). Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J. Oral Maxillofac. Surg. 54, 729-736.
18. Orenstein, A., Kostenich, G., Kopolovic, Y., et al. (1999). Enhancement of ALA-PDT damage by IR-induced hyperthermia on a colon carcinoma model. Photochem. Photobiol. 69, 703-707.
19. Casas, A., Perotti, C., Saccoliti, M., et al. (2002). ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumor organ culture. Br. J. Cancer 86, 837-842.
20. Morgan, J., Gray, A.G., and Huehns, E.R. (1989). Specific targeting and toxicity of sulphonated aluminium phthalocyanine photo-sensitized liposomes directed to cells by monoclonal antibody in vitro. Br. J. Cancer 59, 366-370.
21. Li, W., Zhang, J., Ohnishi, K., et al. (2001). 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells. J. Photochem. Photobiol. B Biol. 60, 79-86.
22. Van den Boogert, J., Van den Staveren, H.J., De Bruin, R.W.F., et al. (2001). Fractionated illumination for oesophageal ALA-PDT effect on blood flow and PpIX formation. Lasers Med. Sci. 16, 16-25.
23. De Rosa, F.S., Marchetti, J.M., Thomazini, J.A., et al. (2000). A vehicle for photodynamic therapy of skin cancer, influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J. Controlled Rel. 65, 359-366.
24. Fijan, S., Honigsmann, H., and Ortel, B. (1995). Photodynamic therapy of epithelial skin tumors using delta-aminolevulinic acid and desferrioxamine. Br. J. Dermatol. 133, 282-288.
25. Bhasin, G., Kausar, H., and Athar, M. (2002). Protoporphyrin-IX accumulation and cutaneous tumor regression in mice using a ferrochelatase inhibitor. Cancer Lett. 187, 9-16.
26. Emanuelli, T., Pagel, F.W., Alves, L.B., et al. (2001). Inhibition of adenylate cyclase activity by 5-aminolevulinic acid in rat and human brain. Neurochem. Int. 38, 213-218.